Roger Redondo is a passionate neuroscientist and drug developer who leads the Systems Neuroscience Section at Roche. Since 2022, they have focused on accelerating drug discovery by exploring how therapies affect neuronal function, while managing multiple laboratories. Previously, Roger served as a Principal Scientist and Senior Scientist at Roche, where they directed projects addressing neurodevelopmental and neurodegenerative disorders. Their academic background includes a PhD in Neuroscience from the University of Edinburgh, along with postdoctoral research at MIT's Picower Institute for Learning and Memory. Roger is also an advocate for generative AI, implementing innovative workflows in drug development.
This person is not in the org chart
This person is not in any teams
This person is not in any offices